Propofol reduces systemic vascular resistance and suppresses cardiac function when injected rapidly. In this study we investigated whether blood pressure decrease after a minimal dose (test-dose) injection of propofol correlates with that after an induction-dose injection.
Propofol is widely used for anaesthesia induction, maintenance and sedation, because of its rapid clearance and because residual effects are rarely seen on awakening 1 . However, anaesthesia induction with propofol is associated with several adverse effects, such as pain on injection, apnoea, myoclonus and hypotension, the most significant of these being decrease in systemic blood pressure 2 . Propofol reduces systemic vascular resistance and suppresses cardiac function when injected rapidly. Haemodynamic suppression may increase the risk of anaesthesia-related complications in patients with cardiovascular disease.
Although several risk factors for hypotensive episodes have been proposed 3 , it is difficult to predict exactly which patients will not tolerate this cardiovascular suppression. The degree of suppression induced by propofol is also variable among subjects with risk factors for hypotension. Reves et al suggested that hypotensive episodes after administration of propofol are more common among patients with dehydration or poor general condition, and in patients undergoing cardiac surgery 1 . In patients over 60 years, a smaller dose is recommended for anaesthesia induction, because excessive hypotension is often observed if propofol is administered using doses required for younger patients 4 . If a simple and reliable method to predict hypotension following propofol injection could be devised, anaesthetists could develop strategies to prevent hypotensive episodes in high-risk patients.
In this study, we investigated whether the blood pressure decrease after a minimal-dose injection (0.4 mg/kg) of propofol correlates with the decrease in systolic blood pressure after an induction-dose injection, to assess if a test-dose can predict hypotension following induction. As the induction dose, we used 1.5 mg/kg and 2.0 mg/kg, which had been used for elderly patients in previous studies [5] [6] . Adverse effects of the test-dose injection were also assessed.
METHODS
The Institutional Ethics Committee of Gunma University approved the study protocol, and written informed consent was obtained from each patient. All patients (n=121) were without severe systemic disease (American Society of Anesthesiologists physical status 1 or 2), and classified as NYHA (New York Heart Association) group 1. No patient had a history of hypertension or was taking antihypertensive medication. Patients matched to the criteria and cared for within a study period for three months were randomly divided by random number table allocation into two groups; anaesthesia was induced in group A (n=60) using 1.5 mg/kg propofol and in group B (n=61) using 2.0 mg/kg. Patients requiring a rapid sequence induction and intubation were excluded. Monitoring consisted of expired carbon dioxide (CO 2 ), arterial blood oxygen saturation (SpO 2 ), blood pressure (non-invasive), and electrocardiography (M1092A; Hewlett Packard, Saronno, Italy). The Bispectral Index monitor (BIS version 3.05.05, Aspect Medical Systems, Natick, MA; BIS sensor #186-0100, Aspect Medical Systems Inc., Newton, MA) was pasted on the forehead as instructed by the manufacturer after a skin preparation with an electrode gel (SkinPure; Nihon Koden Inc., Tokyo). Impedance was confirmed as less than 15k prior to each measurement. ST segment change was automatically examined by the electrocardiography. Measured values were recorded automatically every minute and stored for analysis. The fasting time before surgery was 12 hours and no patient received premedication prior to induction.
An intravenous (IV) catheter was inserted into a left forearm vein, and Hartmann's solution was infused at 10 ml/kg/h. Fluid volume prior to anaesthetic induction was approximately 4-6 ml/kg. Patients in both groups received 0.4 mg/kg propofol as a minimal dose while breathing room air. This was because a bolus injection of less than 0.4 mg/kg did not induce any apparent blood pressure alteration in our preliminary study. The IV line was then flushed twice with 10 ml of Hartmann's solution. Following injection, anaesthetists called the patient by name every 20 seconds. Patient responses were classified by the anaesthetist into five categories: no change, disinhibition (loquaciousness or movement of extremities), sedated (slow and blurred response to verbal commands), drowsy (eye-opening in response to verbal commands, otherwise asleep) and anaesthetized (unresponsive to verbal command). Three minutes after this test dose, patients were given 100% oxygen through a face mask. Propofol (1.5 or 2 mg/kg) was administered by an assistant, using a 10 second bolus injection (0.15-0.2 mg/kg/s). The anaesthetist was blinded to the dose injected. After confirming loss of consciousness, patients were ventilated manually (approximately 10 ml/kg, 12 breaths/min) with 100% oxygen for at least two minutes. As the medical procedures being performed at three minutes post injection (including antihypotensive medication) varied in each subject, data collection was discontinued at that time. Maximal blood pressure change was determined by comparing the values measured every minute.
Data are expressed as mean ± SD. Numerical values in demographics were compared by unpaired t-test, and gender distribution was compared by χ 2 test. Blood pressure, heart rate, SpO 2 and BIS data were compared using repeated measures twoway analysis of variance (ANOVA). A P value less than 0.05 was considered statistically significant. Differences among mean values were analysed using one-way ANOVA with Scheffe's post-hoc test. To evaluate correlations between blood pressures at 3 min after the test dose and at 2 minutes after the induction-dose injection, Pearson's correlation analysis was performed. Regression lines were drawn by simple regression analysis using StatView 5.0 computer software (SAS Institute Inc., Cary, NC). Prior to t-test or ANOVA, normality of data was examined by Kolmogorov-Smirnov test using other statistical software (StatMate III; Atoms Inc., Tokyo). Data analysis was performed by an individual blinded to the study protocol.
RESULTS
Patient characteristics are listed in Table 1 . Age (20-91 years in group A and 25-84 years in group B), body weight, height and gender distribution were not significantly different.
After minimal-dose injection, 18 of 121 patients (13 group A; 5 group B) showed behaviour suggesting disinhibition. Five patients (3 group A; 2 group B) were sedated, and seven patients (5 group A; 2 group B) were drowsy. In both groups, SpO 2 values did not change significantly after minimal-dose injection ( Table 2 ). The value increased to 100% after induction-dose injection in almost all patients in both groups, because 100% oxygen was used for ventilation. Heart rate did not change significantly throughout the study period in either group (Table 2) . No patient showed an ST segment abnormality on electrocardiograph. Blood pressure and BIS values assessed over time using repeated measures ANOVA were not significantly different between the two groups (Figures 1 and 2) . Blood pressure and BIS values were not significantly reduced after the test-dose injection. The power to detect a 10 mmHg change in systolic blood pressure at 5% level of significance was 93% in group A and 81% in group B. The power to detect a 10 mmHg change in diastolic blood pressure and 10% change in BIS value was more than 99% for both groups. Reduction of these blood pressure values was observed after the induction-dose injection (P<0.01). BIS values at 2 min after induction-dose injection were significantly different between the two groups (P<0.05), however, blood pressures at 2 min after the 525 induction-dose injection were not significantly different. The power to detect a 10 mmHg change in systolic and diastolic blood pressure at 5% level of significance was 83% and 99%, respectively. In both groups, a positive correlation was observed between blood pressure reductions after the test-dose injection and those after the induction-dose injection analysis (P<0.01, Pearson's correlation, Figures 3-4) . R values for systolic and diastolic blood pressures in group A were 0.712 and 0.559 respectively, while those in group B were 0.758 and 0.436 respectively. When correlations were re-calculated using percentage changes in blood pressure (blood pressure reduction after injection/pre-injection blood pressure), R values for systolic and diastolic blood pressures were 0.665 and 0.475 in group A and 0.695 and 0.455 in group B.
DISCUSSION
Previous studies have examined the circulatory, respiratory and cerebral effects of propofol when injected or infused at higher doses for anaesthesia induction 1-3 . However, these effects have not been studied with doses less than 1.0 mg/kg. In the present study, we used 0.4 mg/kg propofol as the test dose. Although higher doses induce more obvious effects on circulatory or respiratory parameters, a minimal dose was considered to be most appropriate for test purposes. If the test dose induced comparable adverse effects to the induction dose, it could not be thought of as "a test". In the present study, we waited three minutes before the induction-dose injection. This was because a longer waiting time after the test-dose injection was not considered practical in a clinical setting. However, it is possible that the effects of the test dose were not completely diminished by this time and the effects of induction dose we observed may have been affected. Further study, waiting for longer period to obtain a complete recovery of circulatory parameters after the test dose injection, may reveal a more precise relationship between the effects of test dose and induction dose.
The induction-dose injection reduced systolic blood pressure by approximately 29% in groups A and B. The degree of reduction after the induction-dose injection was comparable to results reported by Ground et al 7 . The test-dose injection in groups A and B reduced systolic blood pressure by approximately 12%. Lam reviewed the literature and reported that the mean blood pressure should not be reduced to less than 60 mmHg 8 . Elliott recommended a reduction in mean arterial pressure of no more than 30% in deliberate hypotension 9 . The degree of blood pressure reduction after our test-dose injection was less than these criteria. Heart rate did not change after test-dose injection or after induction-dose injection. A minimal effect on heart rate was reported previously [2] [3] . The effects of a test dose injection on respiratory function were also considered minimal. Although an induction dose of propofol has been reported to result in a 25-30% incidence of apnoea 10 , reduction in SpO 2 after test-dose injection in this study was less than 1% and recovered without intervention. In this study we observed behavioral change suggesting disinhibition in 15% of the subjects. This incidence should not be dismissed, but the symptoms were not considered serious. Although previous studies have reported that propofol may induce hallucinations and sexual fantasies [11] [12] , such extreme behaviour was not observed in this study. Ibrahim et al demonstrated that excitement-disinhibition (agitation and uncontrollable movement) occurred in 36% of patients who were sedated with propofol (10-60 mg bolus and 25-175 µg/kg/min infusion) during surgery 13 . However, in their study, BIS values were less than 90. The decrease in BIS value in the present study was minimal after the test-dose injection.
All patients in both groups were anaesthetized by 1.5 or 2.0 mg/kg propofol, supporting a previous report by Peacock et al 4 . They demonstrated that the minimum bolus induction dose of propofol was 1.46 mg/kg in subjects younger than 50 years and 0.82 mg/kg in subjects older than 62 years. However, Dundee et al reported that the frequency of anaesthetic induction using 1.5 mg/kg propofol was 53% and 87% with 2.0 mg/kg in subjects under 60 years 5 . The discrepancy between these reports may be explained by differences in administration speed, premedication or ethnic origin. In the present study, we administered doses by body weight, an approach often used for bolus injection. However, the distribution volume of propofol does not depend solely on body weight. When multiple parameters, such as age, body weight, height, gender and circulating blood volume are used to decide the dose of propofol, variations in the required dose for induction and the circulatory effects after induction might be smaller than when the dose is decided solely by body weight.
To prevent hypotension after administration of propofol, several strategies have been proposed. Michelsen et al proposed prophylactic administration of ephedrine to counteract the hypotensive effects of propofol in female elderly patients 14 . Meersschaert et al demonstrated that a vasopressin analogue administered with ephedrine was effective for patients taking angiotensin converting enzyme inhibitor 15 . Dopamine infusion 16 and use of diluted propofol 17 have also been proposed to stabilize haemodynamics during propofol induction. However, application of these strategies to all patients may be costly and impractical. Applying these strategies only if a testdose injection indicates serious hypotension is likely after anaesthetic induction, is more reasonable. We did not assess the blood pressure change following a test-dose injection that would indicate the need for an antihypotensive strategy during anaesthetic induc-tion. Also, because our patients varied widely in age and the scheduled surgical procedure, we could not determine for which patients this test dose method appeared most beneficial. Prediction of hypotension may be more important for patients with poor general condition (American Society of Anesthesiologists physical status 3-5), but these patients were excluded in this study. To establish an accurate and reliable method to predict the blood pressure reduction after anaesthetic induction with propofol, further study involving many patients with multiple backgrounds may be valuable. Also, research of various interventions will be required to establish a strategy to prevent hypotension during propofol induction.
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